The Renal Anhydramnios Fetal Therapy (RAFT) trial is a study of serial amnioinfusions to prevent lethal neonatal pulmonary hypoplasia from early renal anhydramnios. Infant neurologic outcomes were not originally evaluated. We describe the high incidence of stroke observed among infants in the treatment arm of the trial at our center.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11239294 | PMC |
http://dx.doi.org/10.1016/j.jpeds.2024.114053 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!